Insights Into Participating in Studies for Bone Cancer

Clinical studies, with a distinct focus on bone cancer, play a crucial role in evaluating the safety and effectiveness of novel treatments for this disease. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption.

The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Bone Cancer Bone Diseases Bone Neoplasms Musculoskeletal Diseases Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
Diagnosis of bone cancer
No prior treatment for bone cancer

Exclusion criteria

Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Enrolled in another research study
Inability to provide written informed consent

Treatment and study plan

Primary outcomes

Rate of patients who decide to enroll in a bone cancer clinical research.

Time frame: 3 months
Number of bone cancer study participants who remain in clinical study until completion.

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

4159004227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Examining Patient Involvement Patterns and Trends in Participation in Bone Cancer Clinical Trials

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2026
First posted: Oct 6, 2023
Registry last updated: Oct 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting